Condition: Urothelial Carcinoma · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It will also test how safe the drug is for participants. Participants will have cancer that has spread in the body near where it started (locally advanced) and cannot be removed (unresectable) or has spread through the body (metastatic). It will also study what side effects happen when participants get the drug. A side effect is anything a drug does to your body besides treating the disease.
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Banner Gateway Medical Center | Gilbert, Arizona, United States | Recruiting |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| Kaiser Permanente Anaheim Kraemer Medical Offices | Anaheim, California, United States | Recruiting |
| Foothill Cardioology | Arcadia, California, United States | Recruiting |
| Kaiser Permanente Baldwin Park Medical Center | Baldwin Park, California, United States | Recruiting |
| Kaiser Permanente Bellflower Medical Offices | Bellflower, California, United States | Recruiting |
| Beverly Hills Multi-Specialties Practice | Beverly Hills, California, United States | Recruiting |
| Providence Saint Joseph Medical Center | Burbank, California, United States | Recruiting |
| UCLA Burbank Cardiology | Burbank, California, United States | Recruiting |
| UCLA Hematology/Oncology - Burbank | Burbank, California, United States | Recruiting |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Duarte, California, United States | Active Not Recruiting |
| UCLA Encino Specialty Care (Radiology) | Encino, California, United States | Recruiting |
+ 209 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04879329